http://www.fool.com.au/2017/01/20/data3-limited-rockets-on-profit-update-is-it-a-buy/ RXP still considered as top pick in the industry.
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025